TopFunds

Boston Scientific Corporation

NYSE: BSX

Stock price

43.34 USD

(-2.32%) 5 years

Medical - Devices

Insider Transactions

5Y price score: (3)
Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

5Y return: -2.32%
DATE RANGE:
USD PER SHARE

  • Stock price
  • Sales
  • Purchases
  • Stock awards

Transaction History

Trade log
DateActionSharesPriceShare ValueHoldingNameTitleSource
25-aug.-26Purchase2,04049.2100,40813,784Morano Susan Edirectorlink
05-aug.-26Purchase2,10047.699,93717,160Habiger David Cdirectorlink
04-aug.-26Purchase14048.66,80215,060Habiger David Cdirectorlink
03-aug.-26Purchase1,04248.150,08414,920Habiger David Cdirectorlink
03-aug.-26Purchase186,24048.39,001,4081,590,024Mahoney Michael Fdirector, officer: Chairman, President & CEOlink
31-jul.-26Purchase5,00045.5227,40030,359LUDWIG EDWARD Jdirectorlink
20-may.-26Purchase1,77056.599,9871,770Pegus Cheryldirectorlink
20-may.-26Purchase3,58056.7202,91425,359LUDWIG EDWARD Jdirectorlink
20-may.-26Purchase2,25055.9125,81913,878Habiger David Cdirectorlink
19-may.-26Purchase2,20056.9125,27911,628Habiger David Cdirectorlink

42.2

52-week range

105.6

43.34

Your model inputs

Required return / cost of capital
%
FCFF terminal growth rate
%

Your fair value & Margin of safety

To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

Forecast:

Set price notification

Valuation

Free Cash Flow Yield

Help
FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

5.6 %

Dividend Yield TTM

-

Market cap $

$ 64,419

Price / Earnings TTM

Help
P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

17.6

Price / Book TTM

2.6

PEG TTM

Help
Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

0.3

Earnings growth and return

LTM

5YR

10YR

Total return (price & dividends)

(55.9) %

(2.3) %

84.4 %

Free cash flow per share growth

17.4 %

206.3 %

830 %

Earnings per share growth

15.1 %

2,489.2 %

1,177.8 %

Analyst ratings

Price Target Low

50

Price Target High

100

Price Target Median

63.5

Buy

37

Hold

7

Sell

0

Financials

all figures in USD Millions except per share data

Periods:

View:

Forecast:

Help

Averages

based on historical growth rates (CAGR) and average margins for last 10 or max, available and up to 10 years.

Analysts

Average Revenue and Net Income forecast estimates from analysts who cover the stock.

Custom

you can edit default forecast based on averages or analysts consensus and use it to calculate fair value based on your assumptions.

ㅤ

Actual
10 year gagr
Estimated
Projected
Fiscal
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Average (A)
2026
2027
2028
2029
2030
Terminal
FISCAL PERIOD END DATES
SHOW FORECAST VS ACTUAL
01Earnings per share
Help
Diluted EPSLearn more
(0.2)
0.3
0.1
1.2
3.3
(0.1)
0.7
0.4
1.1
1.3
1.9
-
1.5
1.6
1.8
2
2.1
2.2
02FCF per share
0.3
0.4
0.8
-
1
0.8
0.9
0.6
1.2
1.8
2.4
25%
1.5
1.6
1.7
1.8
2
1.9
03Dividends per share
Help
Adjusted for splitsLearn more
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
04Dividends payout, %
-
-
-
-
-
(34.2)%
5.3%
7.9%
1.8%
-
-
-
-
-
-
-
-
-
05Revenue
$ 7,477
$ 8,386
$ 9,048
$ 9,823
$ 10,735
$ 9,913
$ 11,888
$ 12,682
$ 14,240
$ 16,747
$ 20,074
10.4%
$ 22,158
$ 24,458
$ 26,996
$ 29,799
$ 32,892
$ 33,879
06ㅤ% Change
-
12.2%
7.9%
8.6%
9.3%
(7.7)%
19.9%
6.7%
12.3%
17.6%
19.9%
10.4%
10.4%
10.4%
10.4%
10.4%
10.4%
10.4%
07Net Income
(239)
347
104
1,671
4,700
(82)
1,040
698
1,593
1,854
2,886
-
2,275
2,511
2,772
3,060
3,377
3,479
08ㅤ% Margin
(3.2)%
4.1%
1.2%
17%
43.8%
(0.8)%
8.8%
5.5%
11.2%
11.1%
14.4%
10.3% A
10.3%
10.3%
10.3%
10.3%
10.3%
10.3%
09CFO
600
972
1,426
310
1,836
1,508
1,871
1,526
2,503
3,435
4,534
22.4%
3,209
3,542
3,909
4,315
4,763
4,906
10ㅤ% Of revenue
8%
11.6%
15.8%
3.2%
17.1%
15.2%
15.7%
12%
17.6%
20.5%
22.6%
14.5% A
14.5%
14.5%
14.5%
14.5%
14.5%
14.5%
11CAPEX
(247)
(376)
(319)
(316)
(461)
(376)
(554)
(612)
(800)
(790)
(876)
13.5%
(994.2)
(1,128)
(1,281)
(1,454)
(1,650)
(1,872)
12ㅤ% Change
-
52.2%
(15.2)%
(0.9)%
45.9%
(18.4)%
47.3%
10.5%
30.7%
(1.3)%
10.9%
13.5% A
13.5%
13.5%
13.5%
13.5%
13.5%
13.5%
13FCFF
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities (09) – Capital Expenditures (11)Learn more
353
596
1,107
(6)
1,375
1,132
1,317
914
1,703
2,645
3,658
26.3%
2,215
2,413
2,629
2,862
3,113
3,034
14Total assets
18,133
18,096
19,041
20,998
30,565
30,778
32,230
32,470
35,136
39,395
43,673
9.2%
47,686
52,067
56,851
62,074
67,777
74,005
15ㅤ% Change
-
(0.2)%
5.2%
10.3%
45.6%
0.7%
4.7%
0.7%
8.2%
12.1%
10.9%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
9.2%
16Total liabilities
11,813
11,363
12,030
12,273
16,688
15,451
15,607
14,896
15,606
17,392
19,201
5%
20,965
22,891
24,995
27,291
29,799
32,536
17ㅤ% Of assets
65.2%
62.8%
63.2%
58.5%
54.6%
50.2%
48.4%
45.9%
44.4%
44.2%
44%
44% A
44%
44%
44%
44%
44%
44%
18Shareholders Equity
6,320
6,733
7,011
8,725
13,877
15,327
16,623
17,574
19,530
22,003
24,472
14.5%
26,721
29,176
31,856
34,783
37,979
41,468
19Net Debt
5,358
5,288
5,390
6,884
10,060
7,805
7,526
8,354
8,627
10,733
10,373
6.8%
-
-
-
-
-
-
20Shares Outstanding
Help
Diluted Weighted-average Shares OutstandingLearn more
1,341,200
1,377,200
1,392,700
1,401,400
1,410,600
1,416,700
1,433,800
1,439,700
1,463,500
1,485,900
1,494,500
1.1%
1,510,762
1,527,202
1,543,820
1,560,619
1,577,601
1,594,767
21ㅤ% Change
-
2.7%
1.1%
0.6%
0.7%
0.4%
1.2%
0.4%
1.7%
1.5%
0.6%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
1.1%
22ROA
(1.3)%
1.9%
0.6%
8%
15.4%
(0.3)%
3.2%
2.2%
4.5%
4.7%
6.6%
-
4.8%
4.8%
4.9%
4.9%
5%
4.7%
23ROE
(3.8)%
5.2%
1.5%
19.2%
33.9%
(0.5)%
6.3%
4%
8.2%
8.4%
11.8%
-
8.5%
8.6%
8.7%
8.8%
8.9%
8.4%
24Interest coverage
3.3
5.3
6.6
6.5
3.3
1.3
5.5
3.9
8
6.8
11.4
-
-
-
-
-
-
-
25Dividend Yield
-
-
-
-
-
0.1%
0.1%
0.1%
-
-
-
-
-
-
-
-
-
-
26P/E Ratio
(102.4)
83.2
309.9
29.2
13.4
(442.7)
61.3
103.1
53.5
70.9
48.6
-
-
-
-
-
-
-
27Stock price range
13-19
16-24
22-30
25-39
33-45
26-46
35-46
35-47
45-58
58-92
89-108
-
-
-
-
-
-
-
28Market Cap
Help
End of Period Market CapLearn more
24,484
29,365
33,965
48,805
62,924
50,930
60,419
66,189
83,998
131,434
141,156
19.2%
26,646
30,324
34,370
38,820
43,715
-
29FCF Yield
1.4%
2%
3.3%
(0)%
2.2%
2.2%
2.2%
1.4%
2%
2%
2.6%
6%
8.3%
8%
7.7%
7.4%
7.1%
-
30Average stock price
16.1
20.3
25.8
32.1
39.1
35.8
40.6
41.2
51.5
74.6
98.8
19.9%
17.6
19.9
22.3
24.9
27.7
-
31 CEO
MM
Michael F. Mahoney